Martingale Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
64,493
+32,009
| +99% | +$765K | 0.04% | 364 |
|
|
2025
Q1 | $807K | Buy |
+32,484
| New | +$807K | 0.02% | 508 |
|
|
2023
Q3 | – | Sell |
-6,507
| Closed | -$261K | – | 830 |
|
|
2023
Q2 | $261K | Hold |
6,507
| – | – | 0.01% | 722 |
|
|
2023
Q1 | $266K | Sell |
6,507
-29,510
| -82% | -$1.2M | 0.01% | 728 |
|
|
2022
Q4 | $1.39M | Buy |
36,017
+2,804
| +8% | +$108K | 0.03% | 357 |
|
|
2022
Q3 | $1.77M | Buy |
33,213
+3,501
| +12% | +$186K | 0.04% | 281 |
|
|
2022
Q2 | $1.73M | Buy |
29,712
+291
| +1% | +$17K | 0.03% | 309 |
|
|
2022
Q1 | $2.25M | Buy |
29,421
+2,500
| +9% | +$191K | 0.03% | 256 |
|
|
2021
Q4 | $1.62M | Hold |
26,921
| – | – | 0.02% | 366 |
|
|
2021
Q3 | $1.51M | Buy |
26,921
+19,918
| +284% | +$1.12M | 0.02% | 392 |
|
|
2021
Q2 | $425K | Hold |
7,003
| – | – | ﹤0.01% | 636 |
|
|
2021
Q1 | $491K | Sell |
7,003
-1,600
| -19% | -$112K | 0.01% | 613 |
|
|
2020
Q4 | $515K | Sell |
8,603
-9,214
| -52% | -$552K | 0.01% | 604 |
|
|
2020
Q3 | $1.07M | Sell |
17,817
-9,405
| -35% | -$566K | 0.01% | 615 |
|
|
2020
Q2 | $1.43M | Hold |
27,222
| – | – | 0.02% | 636 |
|
|
2020
Q1 | $913K | Buy |
+27,222
| New | +$913K | 0.01% | 706 |
|
|
2019
Q2 | – | Sell |
-29,721
| Closed | -$1.13M | – | 1051 |
|
|
2019
Q1 | $1.13M | Sell |
29,721
-498
| -2% | -$19K | 0.01% | 755 |
|
|
2018
Q4 | $1.3M | Buy |
+30,219
| New | +$1.3M | 0.02% | 641 |
|
|
2015
Q2 | – | Sell |
-2,300
| Closed | -$205K | – | 892 |
|
|
2015
Q1 | $205K | Sell |
2,300
-102
| -4% | -$9.09K | ﹤0.01% | 839 |
|
|
2014
Q4 | $213K | Sell |
2,402
-5,802
| -71% | -$514K | 0.01% | 816 |
|
|
2014
Q3 | $796K | Buy |
+8,204
| New | +$796K | 0.02% | 567 |
|